Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
65 participants
OBSERVATIONAL
2021-12-10
2026-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
We will collect peripheral blood samples from patients diagnosed with sepsis and from non-sepsis control participants. From these samples, we will isolate peripheral blood mononuclear cells (PBMCs) and serum.
We will then analyze these components to measure the activity of specific genes and the levels of key inflammatory factors (cytokines).
The information we gather will help researchers identify molecular and inflammatory markers associated with sepsis. This knowledge is crucial for developing new and more effective methods for diagnosing and treating this critical illness.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison the Value of Several Biomarkers of Sepsis
NCT01388725
Identification and Clinical Efficacy Analysis of Biomarkers in Sepsis Patients
NCT05911711
A Blood Test to Diagnose Sepsis in Symptomatic Adults and Children
NCT05142813
Study on the Establishment of a System for Early Warning and Prognostic Evaluation of Patients With Sepsis
NCT05229328
Effect of Immunophenotype on Prognosis of Sepsis
NCT05602584
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non-sepsis patients
Sepsis patients
Gene and Inflammatory Marker Analysis in Sepsis
1.Sepsis Group:
1. SOFA score \>=2;
2. Aged 18-70 years male and female;
3. Hospitalization. 2.Non-sepsis Group:
(1) Healthy adults; (2) Aged 18-70 years male and female.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gene and Inflammatory Marker Analysis in Sepsis
1.Sepsis Group:
1. SOFA score \>=2;
2. Aged 18-70 years male and female;
3. Hospitalization. 2.Non-sepsis Group:
(1) Healthy adults; (2) Aged 18-70 years male and female.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ruijin Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shanghai JiaoTong University School of Medicine
Shanghai, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
81900073
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
Sepsis-2021-278
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.